Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests

被引:12
作者
Brenner, Hermann [1 ]
Altenhofen, Lutz [2 ]
Tao, Sha [1 ]
机构
[1] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany
[2] Cent Res Inst Ambulatory Hlth Care Germany, D-10623 Berlin, Germany
关键词
Bias; Early detection; Matching; Screening; Specificity; Statistical methods; OCCULT BLOOD-TESTS; COLORECTAL ADENOMA DETECTION; CARCINOEMBRYONIC ANTIGEN; SERUM PEPSINOGEN; GASTRIC-CANCER; AVERAGE RISK; POPULATION; PERFORMANCE; MARKERS; PLASMA;
D O I
10.1016/j.jclinepi.2012.09.008
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: In the evaluation of cancer screening tests, cancer-free controls are often matched to cancer cases on factors such as sex and age. We assessed the potential merits and pitfalls of such matching using an example from colorectal cancer (CRC) screening. Study Design and Setting: We compared sex and age distribution of CRC cases and cancer-free people undergoing screening colonoscopy in Germany in 2006 and 2007. We assessed specificity by sex and age of two immunochemical fecal occult blood tests (iFOBTs) in a study among screening colonoscopy participants conducted in the same years, and we assessed the expected impact of matching by sex and age on the validity of specificity estimates at various cut points. Results: In the screening colonoscopy program, the proportion of men and mean age were 59.6% and 68.6 years among 10,324 CRC patients compared with 45.6% and 64.7 years, respectively, among 997,490 cancer-free participants. The specificity of the iFOBTs was higher among women than among men and decreased with age. Matching of cancer-free controls by age and sex would have led to the underestimation of specificity at all cut points assessed. Conclusion: In the evaluation of cancer screening tests, matching of controls may lead to biased estimates of specificity. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 44 条
[1]  
[Anonymous], 2009, BIOMED ENG
[2]   Molecular Tests for Colorectal Cancer Screening [J].
Bosch, Linda J. W. ;
Carvalho, Beatriz ;
Fijneman, Remond J. A. ;
Jimenez, Connie R. ;
Pinedo, Herbert M. ;
van Engeland, Manon ;
Meijer, Gerrit A. .
CLINICAL COLORECTAL CANCER, 2011, 10 (01) :8-23
[3]   Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies [J].
Brenner, Hermann ;
Hoffmeister, Michael ;
Stegmaier, Christa ;
Brenner, Gerhard ;
Altenhofen, Lutz ;
Haug, Ulrike .
GUT, 2007, 56 (11) :1585-1589
[4]   Low-Dose Aspirin Use and Performance of Immunochemical Fecal Occult Blood Tests [J].
Brenner, Hermann ;
Tao, Sha ;
Haug, Ulrike .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (22) :2513-2520
[5]   Sex Differences in Performance of Fecal Occult Blood Testing [J].
Brenner, Hermann ;
Haug, Ulrike ;
Hundt, Sabrina .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (11) :2457-2464
[6]   Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests [J].
Brenner, Hermann ;
Haug, Ulrike ;
Hundt, Sabrina .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (07) :1643-1649
[7]   Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms A Cohort Analysis [J].
Brenner, Hermann ;
Altenhofen, Lutz ;
Hoffmeister, Michael .
ANNALS OF INTERNAL MEDICINE, 2010, 152 (11) :697-W288
[8]   Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement [J].
Calonge, Ned ;
Petitti, Diana B. ;
DeWitt, Thomas G. ;
Dietrich, Allen J. ;
Gregory, Kimberly D. ;
Harris, Russell ;
Isham, George ;
LeFevre, Michael L. ;
Leipzig, Roseanne M. ;
Loveland-Cherry, Carol ;
Marion, Lucy N. ;
Melnyk, Bernadette ;
Moyer, Virginia A. ;
Ockene, Judith K. ;
Sawaya, George F. ;
Yawn, Barbara P. .
ANNALS OF INTERNAL MEDICINE, 2008, 149 (09) :627-+
[9]   MATCHING [J].
COSTANZA, MC .
PREVENTIVE MEDICINE, 1995, 24 (05) :425-433
[10]   Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients [J].
Douard, R ;
Moutereau, S ;
Serru, V ;
Sales, JP ;
Wind, P ;
Cugnenc, PH ;
Vaubourdolle, M ;
Loric, S .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (02) :127-132